Topics

Ankylosing Spondylitis

Online Consultation System Benefits Rheumatic Disease Management

Online Consultation System Benefits Rheumatic Disease Management

The SSDM series of applications is cost-effective for patients of rheumatologists.

Long-Term Safety of Adalimumab in Immune-Related Diseases Analyzed

Investigators sought to determine the long-term safety of adalimumab use in patients with arthritis and other immune-related diseases.

Predictors of Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Predictors of subclinical accelerated atherosclerosis were examined in a recent study of patients with spondyloarthritis without overt cardiovascular disease.

Minimal Transfer of Certolizumab Pegol to Mature Breast Milk

The first lactation study of its kind evaluated whether a biologic drug is transferred into mature breast milk

FDA Approval of Biosimilar Cyltezo for Multiple Indications

Cyltezo subcutaneous injection has been approved by the FDA.

BMI and Treatment Response to TNF Inhibitors in Ankylosing Spondylitis

In patients with AS, those with a BMI in the overweight or obese range had a lower likelihood of clinical improvement with tumor necrosis factor inhibitor therapy.

Nonradiographic Axial Spondyloarthritis May Be Revealed by MRI

A study analyzes whether underlying sacroiliac erosions may be present in patients with nonradiographic axial spondylarthritis who have normal radiographs.

Syndesmophytes A Superior Imaging Marker of Spinal Fusion than ZJ Fusion

In ankylosing spondylitis, syndesmophytes are a more useful imaging marker of spinal fusion.

Markers of Radiographic Spinal Progression in Ankylosing Spondylitis

Serum leptin and high molecular weight adiponectin have an inverse relationship with radiographic spinal progression in patients with ankylosing spondylitis.

Early Predictors of Poor Long-Term Treatment Response in Spondyloarthritis

Determining which patients are unlikely to respond to therapy early on may help reduce unnecessary treatment and contain costs.

Sign Up for Free e-newsletters